LX1031 Moves Up in the World

Lexicon Pharmaceuticals is moving its drug LX1031 into Phase 2 testing. LX1031, an oral drug for treating the symptoms of IBS, is the second of two drug currently undergoing testing by Lexicon. It is worth noting that once Phase 3 testing is complete, a new drug application can be filed. Houston Business Journal, July 31, 2008 
2008-08-05 19:38:10